Los Angeles Capital Management’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-68,502
| Closed | -$1.14M | – | 1458 |
|
|
2017
Q3 | $1.14M | Buy |
68,502
+780
| +1% | +$12.7K | 0.01% | 779 |
|
|
2017
Q2 | $1.21M | Buy |
67,722
+190
| +0.3% | +$3.55K | 0.01% | 719 |
|
|
2017
Q1 | $1.35M | Buy |
67,532
+11,377
| +20% | +$265K | 0.01% | 648 |
|
|
2016
Q4 | $1.41M | Buy |
56,155
+18,030
| +47% | +$426K | 0.01% | 619 |
|
|
2016
Q3 | $891K | Sell |
38,125
-3,950
| -9% | -$92.8K | 0.01% | 750 |
|
|
2016
Q2 | $841K | Sell |
42,075
-6,325
| -13% | -$118K | 0.01% | 753 |
|
|
2016
Q1 | $820K | Sell |
48,400
-27,541
| -36% | -$564K | 0.01% | 687 |
|
|
2015
Q4 | $1.69M | Buy |
75,941
+580
| +0.8% | +$12.1K | 0.02% | 543 |
|
|
2015
Q3 | $1.28M | Hold |
75,361
| – | – | 0.01% | 629 |
|
|
2015
Q2 | $1.04M | Buy |
75,361
+2,000
| +3% | +$26.6K | 0.01% | 729 |
|
|
2015
Q1 | $1M | Buy |
73,361
+18,230
| +33% | +$210K | 0.01% | 743 |
|
|
2014
Q4 | $583K | Sell |
55,131
-4,515
| -8% | -$53.5K | 0.01% | 796 |
|
|
2014
Q3 | $746K | Sell |
59,646
-1,446
| -2% | -$20.2K | 0.01% | 675 |
|
|
2014
Q2 | $836K | Sell |
61,092
-780
| -1% | -$10.2K | 0.01% | 729 |
|
|
2014
Q1 | $747K | Sell |
61,872
-1,255
| -2% | -$14.4K | 0.01% | 754 |
|
|
2013
Q4 | $776K | Buy |
63,127
+815
| +1% | +$9.56K | 0.01% | 763 |
|
|
2013
Q3 | $634K | Sell |
62,312
-7,405
| -11% | -$69.2K | 0.01% | 835 |
|
|
2013
Q2 | $626K | Buy |
+69,717
| New | +$702K | 0.01% | 831 |
|
Los Angeles Capital Management's OME Position: Q4 2017 in Review
Los Angeles Capital Management sold out of Omega Protein (OME) in Q4 2017, closing a stake of 68,502 shares — an estimated $1.14M sold.
Los Angeles Capital Management first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $1.69M in Q4 2015. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Los Angeles Capital Management reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Los Angeles Capital Management sold 68,502 Omega Protein shares in Q4 2017, an estimated $1.14M.
- Los Angeles Capital Management first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- Los Angeles Capital Management's Omega Protein position peaked at $1.69M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Los Angeles Capital Management's 13F filing for Q4 2017, filed 5 Feb 2018.